Plus Therapeutics

$2.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+5.19%) Today

-$0.03 (-1.23%) As of 10:13 AM UTC after-hours

Why Robinhood?

You can buy or sell PSTV and other stocks, options, and ETFs commission-free!

About PSTV

PLUS THERAPEUTICS, Inc. Common Stock, also called Plus Therapeutics, is a clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its products include Rhenium NanoLiposome (RNL) and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX. The listed name for PSTV is PLUS THERAPEUTICS, Inc. Common Stock.

CEO

Marc H. Hedrick

Employees

Headquarters

Austin, Texas

Founded

1996

Market Cap

11.87M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

231.55K

High Today

$2.54

Low Today

$2.27

Open Price

$2.27

Volume

307.46K

52 Week High

$3.56

52 Week Low

$0.931

Collections

PSTV Earnings

-$5.12

-$3.19

-$1.27

$0.66

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 29, After Hours